Professor Jonathan Ledermann is a Consultant Medical Oncologist, lead medical oncologist and the clinical research lead for gynaecological cancers in the North London Cancer Network, specialising in the treatment of gynaecological and colorectal cancers. His other research interests are in clinical trials and he is head of the UCL Cancer Trials Centre, one of the NCRI-accredited national cancer trials centres funded by research grants from Cancer Research UK. Professor Ledermann has developed and led several national and international trials in gynaecological cancer, currently leading two trials with novel drugs in ovarian cancer.

Professor Ledermann graduated in medicine at UCL and UCH Medical School, subsequently training in medical oncology at UCH, Charing Cross Hospital London, and the Princess Margaret Hospital Toronto, before moving to UCL as a consultant in 1990.

Professor Ledermann is a member of the NCRI clinical studies group for gynaecological cancers and one of the UK representatives on the GCIG (Gynaecological Cancer InterGroup). He has many publications to his name in the field of ovarian and colorectal cancer, serves on editorial boards for professional journals and is a medical advisor to several pharmaceutical companies. He is an acknowledged international expert in ovarian cancer and has lectured widely on his research.

• Treatment of gynaecological and colorectal cancers
• Ovarian cancer (chemotherapy)

• Gynaecological oncology
• Ovarian cancer (chemotherapy)
• Colorectal cancers